Humacyte, Inc.
US ˙ NasdaqGS ˙ US44486Q1031

SecurityHUMA / Humacyte, Inc.
InstitutionXTX Topco Ltd
Latest Disclosed Ownership412,090 shares
Latest Disclosed Value $ 250,015
XTX Topco Ltd reports 36.69% decrease in ownership of HUMA / Humacyte, Inc.

On May 15, 2026 - XTX Topco Ltd filed a 13F-HR form disclosing ownership of 412,090 shares of Humacyte, Inc. (US:HUMA) valued at $250,015 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 650,858 shares of Humacyte, Inc.. This represents a change in shares of -36.69% during the quarter. The current value of the position is $576,926 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HUMACYTE COM 44486Q103 412,090 -238,768 -36.69 250 -60.00 0.0043
2026-02-17 2025-12-31 13F HUMACYTE COM 44486Q103 650,858 457,236 236.15 625 86.01 0.0164
2025-11-14 2025-09-30 13F HUMACYTE COM 44486Q103 193,622 -97,266 -33.44 337 -44.65 0.0175
2025-08-12 2025-06-30 13F HUMACYTE COM 44486Q103 290,888 237,091 440.71 608 567.03 0.0252
2025-05-08 2025-03-31 13F HUMACYTE COM 44486Q103 53,797 9,868 22.46 92 -58.82 0.0047
2025-02-13 2024-12-31 13F HUMACYTE COM 44486Q103 43,929 9,880 29.02 222 19.46 0.0182
2024-11-14 2024-09-30 13F HUMACYTE COM 44486Q103 34,049 11,172 48.84 185 69.72 0.0134
2024-08-12 2024-06-30 13F HUMACYTE COM 44486Q103 22,877 22,877 110 0.0094
2023-05-12 2023-03-31 13F HUMACYTE COM 44486Q103 0 -10,088 -100.00 0 -100.00
2023-02-14 2022-12-31 13F HUMACYTE COM 44486Q103 10,088 10,088 21 0.0045
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.